We are live on ! Find out more
KCM

Kingdon Capital Management Portfolio holdings

AUM $976M
1-Year Est. Return 66.76%
This Fund
S&P 500
This Quarter Est. Return
+9.07%
1 Year Est. Return
+66.76%
3 Year Est. Return
+217.15%
5 Year Est. Return
+352.97%
10 Year Est. Return
+2,412.55%
AUM
$1.82B
AUM Growth
-$379K
Cap. Flow
-$119M
Cap. Flow %
-6.53%
Top 10 Hldgs %
44.11%
Holding
149
New
46
Increased
18
Reduced
22
Closed
49

Sector Composition

Rank Sector Weight
1 Miscellaneous 35.77%
2 Healthcare 12.31%
3 Consumer Staples 12.26%
4 Communication Services 9.07%
5 Energy 7.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLXP
51
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$9.61M 0.53%
121,266
+875
+0.7% +$75.8K
PF
52
DELISTED
Pinnacle Foods, Inc.
PF
$9.26M 0.51%
+200,000
New +$8.7M
SAGE
53
PUT
DELISTED
Sage Therapeutics
SAGE
$9.04M 0.5%
+300,000
New +$10M
HLF icon
54
Herbalife
HLF
$1.3B
$8.78M 0.48%
+300,000
New +$8.98M
REGN icon
55
CALL
Regeneron Pharmaceuticals
REGN
$81.8B
$8.73M 0.48%
+25,000
New +$9.63M
FBC
56
DELISTED
Flagstar Bancorp, Inc. New
FBC
$8.25M 0.45%
+337,873
New +$7.82M
BECN
57
DELISTED
Beacon Roofing Supply, Inc.
BECN
$8.15M 0.45%
179,278
-92,674
-34% -$3.99M
EXEL icon
58
Exelixis
EXEL
$13.5B
$7.92M 0.44%
1,014,130
+685,000
+208% +$3.95M
LLY icon
59
CALL
Eli Lilly
LLY
$1.05T
$7.88M 0.43%
+100,000
New +$7.53M
THS
60
DELISTED
Treehouse Foods
THS
$7.6M 0.42%
+74,000
New +$6.83M
ESRX
61
PUT
DELISTED
Express Scripts Holding Company
ESRX
$7.58M 0.42%
100,000
-180,000
-64% -$13.2M
MNST icon
62
Monster Beverage
MNST
$91.8B
$7.47M 0.41%
558,000
+162,000
+41% +$1.95M
VNDA icon
63
Vanda Pharmaceuticals
VNDA
$320M
$7.21M 0.4%
644,568
+180,000
+39% +$1.74M
PCRX icon
64
Pacira BioSciences
PCRX
$1.03B
$7.13M 0.39%
+211,500
New +$10.4M
LXRX icon
65
Lexicon Pharmaceuticals
LXRX
$1.02B
$7.09M 0.39%
494,380
-30,000
-6% -$407K
ENH
66
DELISTED
Endurance Specialty Holdings Ltd
ENH
$6.92M 0.38%
+103,100
New +$6.76M
HRTX icon
67
CALL
Heron Therapeutics
HRTX
$62M
$6.8M 0.37%
376,700
SGYP
68
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$6.09M 0.34%
+1,603,334
New +$5.43M
EWZ icon
69
PUT
iShares MSCI Brazil ETF
EWZ
$8.16B
$6.04M 0.33%
+200,000
New +$5.52M
MDVN
70
CALL
DELISTED
MEDIVATION, INC.
MDVN
$6.03M 0.33%
+100,000
New +$5.67M
OTIC
71
DELISTED
Otonomy, Inc.
OTIC
$5.84M 0.32%
367,587
+190,000
+107% +$2.83M
SAGE
72
DELISTED
Sage Therapeutics
SAGE
$5.73M 0.32%
+190,100
New +$6.34M
LITE icon
73
Lumentum
LITE
$80.3B
$5.45M 0.3%
225,000
+67,189
+43% +$1.66M
ANAC
74
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$5.41M 0.3%
54,476
-747,034
-93% -$60.4M
GIMO
75
DELISTED
Gigamon Inc.
GIMO
$5.05M 0.28%
135,000
-534,061
-80% -$17M

Similar funds

Kingdon Capital Management's Q2 2016 Portfolio in Review

As of Q2 2016, Kingdon Capital Management held 149 positions worth $1.82B, down 0.02% from $1.82B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Kingdon Capital Management withdrew a net $119M in Q2 2016, closing 49 positions and reducing 22 holdings. Its most notable exit was JARDEN CORPORATION, an estimated $98.4M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 36% of assets, down from 37% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, Kingdon Capital Management opened a new position in EMC CORPORATION worth $39.7M.

  • Kingdon Capital Management's largest Q2 2016 buy was EMC CORPORATION: 1,462,300 shares worth $39.7M.
  • Kingdon Capital Management added most to Newell Brands in Q2 2016, an estimated $88.1M increase.
  • Kingdon Capital Management's biggest Q2 2016 reduction was Alphabet (Google) Class A, cutting an estimated $65.4M.
  • Kingdon Capital Management fully exited JARDEN CORPORATION in Q2 2016, selling an estimated $98.4M.
  • Kingdon Capital Management's ten largest holdings make up 44% of its $1.82B portfolio in Q2 2016.
  • Kingdon Capital Management opened 46 new positions and closed 49 in Q2 2016.
  • Kingdon Capital Management's portfolio value fell 0.02% quarter-over-quarter to $1.82B.

Based on Kingdon Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.